Epitomee Medical Ltd (TLV:EPIT)
Israel · Delayed Price · Currency is ILS · Price in ILA 731.80
+8.30 (1.15%)
At close: Nov 27, 2025
Epitomee Medical Market Cap
Epitomee Medical has a market cap or net worth of 218.31 million as of November 28, 2025. Its market cap has decreased by -24.36% in one year.
Market Cap
218.31M
Enterprise Value
171.86M
Revenue
n/a
Ranking
n/a
PE Ratio
197.94
Stock Price
731.80
Market Cap Chart
Since December 15, 2021, Epitomee Medical's market cap has decreased from 1.21B to 218.31M, a decrease of -81.89%. That is a compound annual growth rate of -35.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 27, 2025 | 218.31M | -19.39% |
| Dec 31, 2024 | 270.81M | 149.63% |
| Dec 31, 2023 | 108.48M | -67.89% |
| Dec 29, 2022 | 337.85M | -63.70% |
| Dec 30, 2021 | 930.82M | -22.80% |
| Dec 15, 2021 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 98.72B |
| Danel (Adir Yeoshua) | 2.73B |
| Kamada | 1.27B |
| Bait Bakfar | 1.03B |
| SofWave Medical | 1.02B |
| BrainsWay | 1.02B |
| Ilex Medical | 707.54M |
| Novolog (Pharm-Up 1966) | 664.14M |